| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/26/2011 | CN101955526A Pseudosciaena crocea MSTN-1 (Myostatin) propeptide, propeptide antibody and preparation method thereof |
| 01/26/2011 | CN101955513A Beta-ureidopropionase epitope, anti-beta-ureidopropionase antibody and application thereof |
| 01/26/2011 | CN101955510A Affinity peptide specific to herceptin and segment thereof |
| 01/26/2011 | CN101953849A Method for preparing anti-duck viral hepatitis transfer factor |
| 01/26/2011 | CN101481691B Trichinella spiralis 70KDa heat shock protein and use thereof |
| 01/25/2011 | US7875705 Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody |
| 01/25/2011 | US7875704 Anti-PLGF antibody |
| 01/25/2011 | US7875703 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases |
| 01/25/2011 | US7875585 Hematopoietic cell E-selectin / L-selectin ligand glycosylated CD44 polypeptide |
| 01/25/2011 | US7875450 Virus-like particles for the induction of autoantibodies |
| 01/25/2011 | US7875436 immobilization; solid phase synthesis; kits |
| 01/25/2011 | US7875421 determining probiotic properties |
| 01/25/2011 | US7875259 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 01/25/2011 | CA2635963C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 01/25/2011 | CA2525499C Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 01/25/2011 | CA2510446C Genes conferring herbicide resistance |
| 01/25/2011 | CA2495743C Fusion proteins and methods of producing same |
| 01/25/2011 | CA2430182C Prokaryotically produced antibodies and uses thereof |
| 01/25/2011 | CA2378519C Human cytokine receptor |
| 01/25/2011 | CA2344467C Ucp4 |
| 01/25/2011 | CA2338186C Tumor necrosis factor-gamma |
| 01/25/2011 | CA2333833C Specific binding molecules for scintigraphy,conjugates containing them and therapeutic method for treatment of angiogenesis |
| 01/25/2011 | CA2312208C Humanization of murine antibody |
| 01/25/2011 | CA2295540C Improved anti-ige antibodies and method of improving polypeptides |
| 01/20/2011 | WO2011008517A2 Immunoglobulin fc polypeptides |
| 01/20/2011 | WO2011008093A1 Means and methods for producing high affinity antibodies |
| 01/20/2011 | WO2011008092A2 Gram-positive bacteria specific binding compounds |
| 01/20/2011 | WO2011007853A1 Monoclonal antibody for cancer-specific isoform |
| 01/20/2011 | WO2011007180A1 Immunodetection and quantification of pyrazolopyrimidine sedatives |
| 01/20/2011 | WO2011006915A2 Improved anti-serum albumin binding single variable domains |
| 01/20/2011 | WO2011006871A1 INHIBITORS OF THE NITRATION OF AMYLOID ß PEPTIDES AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE |
| 01/20/2011 | WO2011006273A1 Combination of a human interleukin-6 antagonist and a human interleukin-6 receptor antagonist in therapy of tumour diseases |
| 01/20/2011 | WO2011006249A1 Mutated sumo isoforms and uses thereof |
| 01/20/2011 | WO2010136483A3 Antigen-binding proteins |
| 01/20/2011 | WO2010125187A3 Method for the production of domain antibodies |
| 01/20/2011 | WO2010118243A3 Use of il-27 antagonists to treat lupus |
| 01/20/2011 | WO2010107752A3 Alpha-4-beta-7 heterodimer specific antagonist antibody |
| 01/20/2011 | WO2010077323A3 Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders |
| 01/20/2011 | WO2009155180A8 Antibodies to il-6 and their uses |
| 01/20/2011 | WO2003034984A9 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 01/20/2011 | US20110016545 Xylanases, Nucleic Acids Encoding Them and Methods For Making and Using Them |
| 01/20/2011 | US20110016538 Susceptibility locus for schizophrenia |
| 01/20/2011 | US20110015374 Method for Commercial Isolation of Egg Yolk IgY, Its Product, and Uses of the Product |
| 01/20/2011 | US20110015344 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 01/20/2011 | US20110015133 Pax2 and pax8 as tumour targets for immunologic and molecular treatment strategies |
| 01/20/2011 | US20110015095 Arachnocampa luciferases |
| 01/20/2011 | US20110014721 Hydrophilic chemiluminescent acridinium labeling reagents |
| 01/20/2011 | US20110014691 Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications |
| 01/20/2011 | US20110014676 Protein stabilization |
| 01/20/2011 | US20110014653 Production of antibodies in avian cells |
| 01/20/2011 | US20110014639 Hybridoma cell line producing monoclonal antibody against foot-and-mouth disease virus, the monoclonal antibody therefrom, immunoassay reagent and kit, and immunoassay method |
| 01/20/2011 | US20110014635 Marker peptide for alzheimer's disease |
| 01/20/2011 | US20110014634 Nucleic acids encoding t2r, a novel family of taste receptors |
| 01/20/2011 | US20110014631 Method for diagnosing acute coronary syndrome |
| 01/20/2011 | US20110014628 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 01/20/2011 | US20110014626 Methods for measuring the insulin receptor alpha subunit |
| 01/20/2011 | US20110014608 SCREENING FOR CD93 (C1qRp)-ASSOCIATED POLYMORPHISM(S) IN THE DIAGNOSIS, PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES |
| 01/20/2011 | US20110014602 Diagnostic composition for hepatocellular carcinoma, a diagnostic kit comprising it and diagnostic methods of hepatocellular carcinoma |
| 01/20/2011 | US20110014599 Novel Fluorescent Dyes and Uses Thereof |
| 01/20/2011 | US20110014270 Prevention and treatment of ischemia-reperfusion injury and related conditions |
| 01/20/2011 | US20110014238 Immunogenic protein pas n 1 from bahia grass pollen |
| 01/20/2011 | US20110014213 Human anti-alpha 9 integrin antibody |
| 01/20/2011 | US20110014210 Chlamydia vaccine |
| 01/20/2011 | US20110014209 Recombinant hcv e2 glycoprotein |
| 01/20/2011 | US20110014206 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor |
| 01/20/2011 | US20110014201 Il-18 receptor antigen binding proteins |
| 01/20/2011 | US20110014200 Monoclonal antibody that suppresses thyrotropin receptor constitutive activity |
| 01/20/2011 | US20110014199 Novel anti-il 13 antibodies and uses thereof |
| 01/20/2011 | US20110014197 Methods of treating pre-eclampsia or eclampsia |
| 01/20/2011 | US20110014193 Humanized anti-human alpha 9-integrin antibody |
| 01/20/2011 | US20110014188 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 01/20/2011 | US20110014187 Monoclonal antibodies capable of reacting with a plurality of influenza virus a subtypes |
| 01/20/2011 | US20110014185 Methods involving graf polypeptides |
| 01/20/2011 | US20110014182 Antigen binding proteins |
| 01/20/2011 | US20110014122 Novel anti-igf-ir and/or anti-insulin/igf-i hybrid receptors antibodies and uses thereof |
| 01/20/2011 | US20110014120 Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging |
| 01/20/2011 | US20110014117 Anti-igf1r |
| 01/20/2011 | CA2805155A1 Inhibitors of the nitration of amyloid .beta. peptides and their uses in the diagnosis and treatment of alzheimer's disease |
| 01/20/2011 | CA2768462A1 Improved anti-serum albumin binding single variable domains |
| 01/20/2011 | CA2768460A1 Antagonists, uses & methods for partially inhibiting tnfr1 |
| 01/20/2011 | CA2768247A1 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
| 01/20/2011 | CA2768207A1 Means and methods for producing high affinity antibodies |
| 01/20/2011 | CA2768204A1 Gram-positive bacteria specific binding compounds |
| 01/20/2011 | CA2768186A1 Rsv f protein compositions and methods for making same |
| 01/20/2011 | CA2767570A1 Mutated sumo isoforms and uses thereof |
| 01/20/2011 | CA2766065A1 Immunoglobulin fc polypeptides |
| 01/20/2011 | CA2765220A1 Methods for inhibiting yellow color and peroxide formation in a composition |
| 01/19/2011 | EP2275818A2 Method for improved early recognition of the seroconversion of an antibody to hepatitis C |
| 01/19/2011 | EP2275814A1 A -oligomer measurement method |
| 01/19/2011 | EP2275575A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275574A2 Coding sequence haplotypes of the human BRCA2 gene |
| 01/19/2011 | EP2275572A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275571A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275570A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275555A2 Genetic sequence coding for creatinine deiminase, and its use |
| 01/19/2011 | EP2275554A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275553A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275552A2 Neisserial antigenic peptides |
| 01/19/2011 | EP2275551A2 Neisserial antigenic peptides |